Where all that glitters is not gold
By Ufrieda Ho – Mineral-rich, prosperous, the glitter of gold – that’s supposed to be the promise of the towns the sit atop the ore-rich western fringe of Gauteng.
By Ufrieda Ho – Mineral-rich, prosperous, the glitter of gold – that’s supposed to be the promise of the towns the sit atop the ore-rich western fringe of Gauteng.
By Anso Thom – For a long time, South Africa has been a country where charlatans are able to flourish and peddle dangerous remedies for all kinds of ailments.
By Ntsiki Mpulo – Eyes bulging, lips cracked, ribs clearly visible under taut skin; the man appears on the verge of taking his last breath.
Delays at the South African National AIDS Council (SANAC) has meant that the new NSP (National Strategic Plan) will now only be ready in March 2017. By Anso Thom and Marcus Low.
The role of community health workers in the South African public healthcare system has been unclear and controversial. How many do we need? What exactly should their role be? Who should employ them? What should they be paid? Is there good evidence to inform policy? Sasha Stevenson of SECTION27 lead Spotlight’s in-depth investigation into these pressing questions.
Open Letter to AIDS Activists across the Globe – By Mark Heywood
By Salmaan Keshavjee – Tuberculosis (TB) has surpassed HIV/AIDS as the biggest infectious killer of adults worldwide. In 2015, an estimated 10.4 million people became sick with the disease – one million of whom were children – and 1.8 million people died.
Marcus Low – Last month the annual Union World Conference on Lung Health was held in Liverpool, United Kingdom. As always at this conferences, much was said about how the world needs to step up the fight against tuberculosis (TB) – about how we need new agendas and paradigm shifts.
The MCC will soon be replaced by the South African Health Products Authority (SAHPRA). Spotlight asked MCC registrar Dr Joey Gouws and MCC chairperson Professor Helen Rees about changes at South Africa’s medicines regulator.
By Mike Frick – The world spent less on tuberculosis (TB) research in 2015 than it did in 2009. This decrease in spending does not track a similar decline in TB incidence or mortality.
By Marcus Low – An online tool launched last week sheds light on what patents have been granted for which medicines in a number of developing countries.
By Marcus Low The recently published outputs of the Thembisa mathematical model of HIV in South Africa paint a remarkable picture of the history of HIV in this country. For…